Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 72
Filter
1.
Phys Rev Lett ; 129(22): 225001, 2022 Nov 23.
Article in English | MEDLINE | ID: mdl-36493430

ABSTRACT

We present a study of perpendicular subcritical shocks in a collisional laboratory plasma. Shocks are produced by placing obstacles into the supermagnetosonic outflow from an inverse wire array z pinch. We demonstrate the existence of subcritical shocks in this regime and find that secondary shocks form in the downstream. Detailed measurements of the subcritical shock structure confirm the absence of a hydrodynamic jump. We calculate the classical (Spitzer) resistive diffusion length and show that it is approximately equal to the shock width. We measure little heating across the shock (<10% of the ion kinetic energy) which is consistent with an absence of viscous dissipation.

3.
Nat Commun ; 7: 13081, 2016 10 07.
Article in English | MEDLINE | ID: mdl-27713403

ABSTRACT

The remarkable discovery by the Chandra X-ray observatory that the Crab nebula's jet periodically changes direction provides a challenge to our understanding of astrophysical jet dynamics. It has been suggested that this phenomenon may be the consequence of magnetic fields and magnetohydrodynamic instabilities, but experimental demonstration in a controlled laboratory environment has remained elusive. Here we report experiments that use high-power lasers to create a plasma jet that can be directly compared with the Crab jet through well-defined physical scaling laws. The jet generates its own embedded toroidal magnetic fields; as it moves, plasma instabilities result in multiple deflections of the propagation direction, mimicking the kink behaviour of the Crab jet. The experiment is modelled with three-dimensional numerical simulations that show exactly how the instability develops and results in changes of direction of the jet.


Subject(s)
Astronomical Phenomena , Magnetic Fields , Models, Theoretical , Plasma Gases , Computer Simulation , Lasers
4.
J Clin Epidemiol ; 54(12): 1195-203, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11750188

ABSTRACT

Disease-specific registries have many important applications in epidemiologic, clinical and health services research. Since 1989 the Department of Veterans Affairs has maintained a national HIV registry. VA's HIV registry is national in scope, it contains longitudinal data and detailed resource utilization and clinical information. To describe the structure, function, and limitations of VA's national HIV registry, and to test its accuracy and completeness. The VA's national HIV registry contains data that are electronically extracted from VA's computerized comprehensive clinical and administrative databases, called Veterans Integrated Health Systems Technology and Architecture (VISTA). We examined the number of AIDS patients and the number of new patients identified to the registry, by year, through December 1996. We verified data elements against information obtained from the medical records at five VA sites. By December 1996, 40,000 HIV-infected patients had been identified to the registry. We encountered missing data and problems with data classification. Missing data occurred for some elements related to the computer programming that creates the registry (e.g., pharmacy files), and for other elements because manual entry is required (e.g., ethnicity). Lack of a standardized data classification system was a problem, especially for the pharmacy and laboratory files. In using VA's national HIV registry we have learned important lessons, which, if taken into account in the future, could lead to the creation of model disease-specific registries.


Subject(s)
HIV Infections/epidemiology , Registries/standards , Veterans , Humans , Pilot Projects , Program Evaluation , Research Design , United States , United States Department of Veterans Affairs
5.
Health Policy Plan ; 16 Suppl 1: 7-12, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11599670

ABSTRACT

This paper discusses some conceptual underpinnings of research on gender and quality of health services and demonstrates the importance of training health professionals about how gender influences the health-illness-care process in men and women. It addresses the need to provide opportunities for health providers to understand how gender influences their own lives and work. It also describes the gendered nature of the health system itself, an aspect that is little understood and hence neglected in the training of health workers and the planning and provision of services. The paper demonstrates the need for interventions such as Health Workers for Change to sensitize health workers to the needs of female clients in particular, but also to their own constraints and challenges as health workers. It is also meant to stimulate further research into these issues, particularly among resource poor populations.


Subject(s)
Health Care Reform/organization & administration , Health Personnel/education , Interpersonal Relations , Prejudice , Quality Assurance, Health Care , Women's Health , Female , Humans , Male , Organizational Innovation , Social Justice
6.
J Bacteriol ; 183(1): 63-70, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11114901

ABSTRACT

Previous studies have demonstrated that a proportion of Staphylococcus aureus isolates from bovine mastitis coproduce toxic shock syndrome toxin (TSST) and staphylococcal enterotoxin C (SEC). In this study, molecular genetic analysis of one such strain, RF122, revealed the presence of a 15,891-bp putative pathogenicity island (SaPIbov) encoding the genes for TSST (tst), the SEC bovine variant (sec-bovine), and a gene (sel) which encodes an enterotoxin-like protein. The island contains 21 open reading frames specifying hypothetical proteins longer than 60 amino acids including an integrase-like gene. The element is bordered by 74-bp direct repeats at the left and right junctions, and the integration site lies adjacent to the 3' end of the GMP synthase gene (gmps) in the S. aureus chromosome. SaPIbov contains a central region of sequence identity with the previously characterized tst pathogenicity island SaPI1 (J. A. Lindsay et al., Mol. Microbiol. 29:527-543, 1998). A closely related strain, RF120, of the same multilocus enzyme electrophoretic type, random amplified polymorphic DNA type, and ribotype, does not contain the island, implying that the element is mobile and that a recent insertion/deletion event has taken place. TSST and TSST/SEC-deficient mutants of S. aureus strain RF122 were constructed by allele replacement. In vitro bovine Vbeta-specific lymphocyte expansion analysis by culture supernatants of wild-type strains and of tst and sec-bovine allele replacement mutants revealed that TSST stimulates BTB13-specific T cells whereas SEC-bovine stimulates BTB93-specific T cells. This suggests that the presence of SaPIbov may contribute to modulation of the bovine immune response.


Subject(s)
Bacterial Toxins , Mastitis, Bovine/microbiology , Staphylococcus aureus/immunology , Staphylococcus aureus/pathogenicity , Superantigens/genetics , Animals , Base Sequence , Blotting, Southern , Cattle , Cloning, Molecular , DNA Transposable Elements , Deoxyribonucleases, Type II Site-Specific/metabolism , Enterotoxins/genetics , Enterotoxins/immunology , Enterotoxins/metabolism , Female , Molecular Sequence Data , Sequence Analysis, DNA , Staphylococcal Infections/microbiology , Staphylococcal Infections/veterinary , Staphylococcus aureus/genetics , Superantigens/immunology , T-Lymphocytes/immunology , Virulence/genetics
7.
Jt Comm J Qual Improv ; 27(12): 664-72, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11765383

ABSTRACT

BACKGROUND: Smoking during pregnancy has been linked with such negative outcomes as increased risk for spontaneous abortions, low birth weight, and perinatal and neonatal mortality. In spring 1998 three leading health care systems in San Diego initiated the Trilateral Partnership ("the Partnership"), whose mission is to improve the health and well-being of children. The Partnership chose tobacco control in pregnant women and their families as its first initiative. PROGRAM COMPONENTS-YEAR ONE (1999): Three interventions were developed: intervention by the prenatal care provider, initiation of a referral process to telephone counseling for pregnant women, and intervention for women reporting spontaneously quitting smoking. To date, 83% of the more-than 20,000 women who have been seen in prenatal screening in 28 months counted themselves as nonsmokers. Eleven percent of the women reported they independently stopped smoking once they learned they were pregnant. Six percent reported that they were still smoking. Twenty-three percent of the women reported living in a household with other smokers. PROGRAM COMPONENTS-YEAR TWO (2000): Activity focused on continuing the previous components, hospital intervention for all new mothers at the time of delivery, pediatric intervention at the newborn's visits at 2 and 6 months of age, and development and refinement of a telephone protocol for new parents. ELEMENTS OF SUCCESS: The noncontroversial topic of encouraging smoking cessation during pregnancy was one that enhanced immediate buy-in by most individuals contacted to support and engage in the program. Strong commitment and financial support from three health care systems opened doors for the Smoke-Free Families staff and increased the program's visibility in the community.


Subject(s)
Guideline Adherence/organization & administration , Health Promotion/organization & administration , Practice Guidelines as Topic , Prenatal Care/organization & administration , Smoking Cessation/statistics & numerical data , Smoking Prevention , Adult , California , Cooperative Behavior , Counseling , Family Health , Female , Hospitals, Pediatric , Humans , Infant Welfare , Infant, Newborn , Outcome Assessment, Health Care , Pregnancy , Program Evaluation , Referral and Consultation , Smoking/adverse effects , Smoking Cessation/methods , Telephone
8.
Anesth Analg ; 91(6): 1370-1, TOC, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11093981

ABSTRACT

IMPLICATIONS: Using certain specialized endotracheal tubes designed to allow single-lung ventilation for certain thoracic surgical procedures may be fraught with technical difficulties owing to common anatomic anomalies. This case report describes a simple solution for an ill-fitting right double-lumen endotracheal tube using a balloon-tipped catheter.


Subject(s)
Intubation, Intratracheal/instrumentation , Aged , Bronchi/anatomy & histology , Bronchi/surgery , Humans , Male , Pneumonectomy
9.
Inquiry ; 37(1): 61-74, 2000.
Article in English | MEDLINE | ID: mdl-10892358

ABSTRACT

This study estimates the impact of clinical and socioeconomic characteristics on health care use for HIV-infected patients. Data come from the Department of Veterans Affairs (VA) HIV Registry, which electronically extracts data from patients' automated medical records, and from patient interviews. Unlike prior studies, this analysis includes a staging system incorporating CD4 count and AIDS-defining diagnoses. Results showed that clinical factors were the most important determinants of health care use; socioeconomic variables were seldom significant. These findings were expected, since the VA is an equal access system, providing care regardless of socioeconomic status.


Subject(s)
HIV Infections/economics , Health Services Accessibility , Health Services/statistics & numerical data , United States Department of Veterans Affairs/statistics & numerical data , Aged , Ambulatory Care/statistics & numerical data , CD4 Lymphocyte Count , Emergency Medical Services/statistics & numerical data , Ethnicity/statistics & numerical data , Health Status , Hospitalization/statistics & numerical data , Humans , Logistic Models , Middle Aged , Multivariate Analysis , Socioeconomic Factors , United States
10.
J Appl Microbiol ; 88(6): 1028-37, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10849179

ABSTRACT

Staphylococcus aureus isolates from cows in Ireland (n = 102) and the USA (n = 42) were characterized by RAPD-PCR and analysed for the production of a number of putative virulence factors. Of these strains 63 representative isolates were screened for the corresponding virulence factor genes by PCR or Southern hybridization or both. The isolates were divided into 12 distinct clonal types on the basis of their RAPD fingerprint profiles. Of the isolates, 107 (74.3%) tested positive for clumping factor in a slide agglutination test, all 24 RAPD type 7 isolates being negative for clumping factor. PCR analysis of region R, a repeat region of the clfA gene, revealed eight region-R sizes. There was a strong association between RAPD type and the clfA region-R genotype among Irish isolates. Of the RAPD type 7 isolates, 21 (87.5%) coproduced toxic shock syndrome toxin-1 (TSST-1) and staphylococcal enterotoxin C (SEC). Over 90% of isolates demonstrated haemolytic activity on sheep or rabbit red blood cells and all isolates harboured the gamma-haemolysin (hlg) locus. Of the Irish isolates, all those of RAPD type 7 were sensitive to penicillin G, whereas 86% of RAPD types 4 and 5 strains were resistant. Furthermore, RAPD types 5 and 7 were more likely to be associated with clinical mastitis whereas RAPD type 4 isolates were more often associated with a latent infection. The current study identifies some of the putative virulence factors produced by the predominant clonal types of bovine Staph. aureus that may be considered as components of a vaccine.


Subject(s)
Bacterial Toxins , Cattle Diseases/microbiology , Genes, Bacterial , Mastitis/veterinary , Staphylococcal Infections/veterinary , Staphylococcus aureus/pathogenicity , Superantigens , Animals , Anti-Bacterial Agents/pharmacology , Blotting, Southern , Cattle , Cattle Diseases/diagnosis , Enterotoxins/genetics , Female , Genetic Variation , Genotype , Hemolysin Proteins/analysis , Hemolysin Proteins/genetics , Ireland , Polymerase Chain Reaction , Random Amplified Polymorphic DNA Technique , Staphylococcus aureus/drug effects , Staphylococcus aureus/genetics , United States , Virulence/genetics
11.
Int Anesthesiol Clin ; 38(1): 1-23, 2000.
Article in English | MEDLINE | ID: mdl-10723667

ABSTRACT

The pathophysiology, medical and surgical management of emphysema have been reviewed as a foundation to the physiological goals and principles of anesthetic management of patients with emphysema. An understanding of the cardiovascular and respiratory consequences of emphysema combined with anesthesia, PPV, and thoracic surgery is essential to achieving the challenging physiological goals of providing anesthesia, positive pressure and one-lung ventilation, and postoperative analgesia in a manner consistent with rapid postoperative extubation, hemodynamic stability, adequate gas exchange, and minimal barotrauma for this population of patients.


Subject(s)
Anesthesia/methods , Pulmonary Emphysema/surgery , Anesthesia/adverse effects , Humans , Positive-Pressure Respiration , Postoperative Complications , Pulmonary Emphysema/physiopathology , Pulmonary Emphysema/therapy , Pulmonary Gas Exchange , Respiration, Artificial
13.
Am J Cardiol ; 82(12): 1445-50, 1998 Dec 15.
Article in English | MEDLINE | ID: mdl-9874045

ABSTRACT

Despite increasing use of percutaneous transluminal coronary angioplasty (PTCA) to treat stenotic coronary artery disease, there are relatively few prospective studies evaluating its long-term effectiveness. We prospectively randomized 212 stable patients with provocable myocardial ischemia and single-vessel subocclusive coronary disease to receive primary therapy with either PTCA or medical therapy. This report presents the clinical follow-up of these patients at a mean, after randomization, of 2.4 years for interview and 3.0 years for exercise testing. Of the 212 patients originally randomized, 175 received an extended follow-up interview, and 132 underwent exercise testing; 62% of patients in the PTCA group were angina free compared with 47% of patients in the medical group (p <0.05). Furthermore, exercise duration as measured by treadmill testing was prolonged by 1.33 minutes over baseline in the PTCA group, whereas it decreased by 0.28 minutes in the medical group (p <0.04). Although the angina-free time on the treadmill was not different (p=0.50), fewer patients in the medical group developed angina on the treadmill at 3 years than those in the PTCA group (p=0.04). By 36 months, excluding the initial randomized PTCA, use of PTCA and use of coronary artery bypass surgery were not different in the 2 treatment groups. These data indicate that some of the early benefits derived from PTCA in patients with single-vessel coronary artery disease are sustained, making it an attractive therapeutic option for these patients.


Subject(s)
Angioplasty, Balloon, Coronary , Coronary Disease/therapy , Adrenergic beta-Antagonists/therapeutic use , Aged , Angina Pectoris/prevention & control , Angioplasty, Balloon, Coronary/methods , Calcium Channel Blockers/therapeutic use , Coronary Disease/drug therapy , Disease-Free Survival , Exercise Test , Female , Follow-Up Studies , Humans , Male , Middle Aged , Nitroglycerin/therapeutic use , Prospective Studies , Treatment Outcome , United States , United States Department of Veterans Affairs , Vasodilator Agents/therapeutic use
14.
Respir Care Clin N Am ; 3(3): 411-34, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9390918

ABSTRACT

A decade of research has identified nitric oxide as a unique endogenous biologic mediator with functions as diverse as vasodilation, macrophage cytotoxicity, platelet adhesion, and memory formation. Measurement devices, previously used in research on atmospheric nitrogen oxides, are being adapted for and applied to clinical situations without approval, regulation, or rigorous testing, and with little understanding of how the devices work or their limitations. This article discusses the chemistry, manufacture, and measurement of nitrogen oxides.


Subject(s)
Environmental Monitoring/methods , Environmental Pollutants/analysis , Nitric Oxide/chemical synthesis , Technology, Pharmaceutical/methods , Administration, Inhalation , Calibration , Drug Design , Drug Monitoring/instrumentation , Drug Monitoring/methods , Environmental Monitoring/instrumentation , Half-Life , Humans , Nitric Oxide/analysis , Nitric Oxide/metabolism , Nitric Oxide/therapeutic use , Technology, Pharmaceutical/instrumentation
15.
J Clin Epidemiol ; 50(11): 1231-40, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9393379

ABSTRACT

This article and the following article (Parts I and II) report the development of two clinical staging systems for HIV-infected individuals. The objective of the research reported here (Part I) was to construct a clinical staging system to predict progression to AIDS. We analyzed data from VA Cooperative Study Number 298, a multicenter, double-blind, randomized trial that compared immediate versus deferred zidovudine therapy in 338 HIV-infected individuals who did not have AIDS at enrollment. Baseline variables were tested in univariate Cox regression for their relationship to progression to AIDS, and those that appeared predictive were examined in multivariable analysis. Based on these analyses, we constructed a new clinical staging system based on CD4+ cell count, age, hemoglobin, oral hairy leukoplakia or oral thrush, and fever. The stages of the system were significant predictors of progression to AIDS (p = 0.0001, log-rank test). In conclusion, simple, valid, clinical staging systems for HIV-infected patients can be constructed using information that is readily available in clinical practice settings. Such systems provide better prognostic distinction than CD4+ cell count alone by taking into account the known prognostic effects of other variables.


Subject(s)
Anti-HIV Agents/therapeutic use , HIV Infections/classification , Veterans , Zidovudine/therapeutic use , Acquired Immunodeficiency Syndrome/diagnosis , Adult , CD4 Lymphocyte Count , Cohort Studies , Disease Progression , Double-Blind Method , Female , HIV Infections/drug therapy , HIV Infections/epidemiology , Humans , Male , Markov Chains , Predictive Value of Tests , Severity of Illness Index , Treatment Outcome
16.
J Clin Epidemiol ; 50(11): 1241-8, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9393380

ABSTRACT

This article (Part II) and the preceding article (Part I) report the development of two clinical staging systems for HIV-infected individuals. The objective of the research reported here (Part II) was to construct a clinical staging system to predict survival in patients with AIDS. We analyzed data from VA Cooperative Study Number 298, a multicenter, double-blind, randomized trial that compared immediate versus deferred zidovudine therapy in HIV-infected individuals. Baseline variables obtained at the onset of AIDS in 204 individuals were tested in univariate Cox regression for their relationship to survival, and those that appeared predictive were examined in multivariable analysis. Based on these analyses, we constructed a new AIDS Clinical Staging System. The system is based on age, CD4+ cell count, type of first AIDS-defining condition, and functional status. The stages of the system were significant predictors of survival (p = 0.0001, log-rank test). In conclusion, valid, simple clinical staging systems for patients with AIDS can be developed based on a few variables that are readily available in clinical settings.


Subject(s)
Acquired Immunodeficiency Syndrome/mortality , Veterans , Acquired Immunodeficiency Syndrome/classification , Acquired Immunodeficiency Syndrome/drug therapy , Adult , Anti-HIV Agents/therapeutic use , Double-Blind Method , Female , Humans , Male , Markov Chains , Predictive Value of Tests , Prognosis , Proportional Hazards Models , Severity of Illness Index , Survival Rate , Treatment Outcome , Zidovudine/therapeutic use
17.
Epidemiol Infect ; 119(2): 261-9, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9363026

ABSTRACT

Sixty-three Staphylococcus aureus isolates recovered from bovine sources in the USA and the Republic of Ireland were characterized by multilocus enzyme electrophoresis (MLEE), ribotyping, and random amplified polymorphic DNA polymerase chain reaction (RAPD-PCR) typing at two separate laboratories. The S. aureus isolates were assigned by MLEE to 10 electrophoretic types (ETs) (Index of Discrimination, D = 0.779). In contrast, the same isolates were assigned to 13 ribotypes (D = 0.888), and to 12 RAPD types (D = 0.898). A common clone, ET3, of worldwide distribution, was represented by six distinct combinations of ribotypes and RAPD types. S. aureus clones recovered from cows in Ireland were also associated with mastitis in dairy cows in the USA. These findings are consistent with the hypothesis that only a few specialized clones of S. aureus are responsible for the majority of cases of bovine mastitis, and that these clones have a broad geographic distribution.


Subject(s)
DNA, Bacterial/genetics , Mastitis, Bovine/microbiology , Staphylococcal Infections/microbiology , Staphylococcal Infections/veterinary , Staphylococcus aureus/genetics , Animals , Cattle , Discriminant Analysis , Electrophoresis, Starch Gel , Female , Ireland/epidemiology , Mastitis, Bovine/epidemiology , Molecular Epidemiology , Random Amplified Polymorphic DNA Technique , Restriction Mapping , Sensitivity and Specificity , Staphylococcal Infections/epidemiology , United States/epidemiology
18.
J Am Coll Cardiol ; 30(5): 1256-63, 1997 Nov 01.
Article in English | MEDLINE | ID: mdl-9350924

ABSTRACT

OBJECTIVES: We sought to evaluate the prognostic ability of cardiac exercise stress tests in predicting cardiac mortality and morbidity in a low risk group of patients with established coronary artery disease (CAD). BACKGROUND: Although previous studies have demonstrated the superior value of stress nuclear cardiac scintigraphy in the prognosis of patients with CAD, none of these studies have focused on patients with a proven angiographic low risk profile (i.e., single- and double-vessel CAD). METHODS: Three hundred twenty-eight patients with documented single- and double-vessel disease were treated by random assignment to percutaneous transluminal coronary angioplasty or medical therapy in the Angioplasty Compared to Medicine (ACME) trial. Six months after randomization, maximal symptom-limited exercise tests were performed with electrocardiography (n = 300) and thallium scintigraphy (n = 270). Patients were followed up for a minimum of 5 years thereafter. RESULTS: A reversible thallium perfusion deficit documented after 6 months of either therapy was associated with an adverse mortality outcome (18% mortality rate with a reversible thallium perfusion defect and 8% mortality rate with no reversible thallium perfusion deficit, p = 0.02). Moreover, an important mortality gradient was demonstrated in relation to the number of reperfusing defects (0 = 7%, 1 to 2 = 15%, >3 = 20%, p = 0.04). Exercise electrocardiography did not predict this mortality outcome. CONCLUSIONS: A reversible thallium perfusion deficit demonstrated 6 months after medical therapy or coronary angioplasty is a valuable prognostic marker in patients with angiographically documented single- and double-vessel disease and is superior to exercise electrocardiography in this regard.


Subject(s)
Coronary Disease/mortality , Electrocardiography , Thallium Radioisotopes , Aged , Angina Pectoris/therapy , Angioplasty, Balloon, Coronary , Coronary Angiography , Coronary Disease/drug therapy , Coronary Disease/therapy , Exercise Test , Heart/diagnostic imaging , Humans , Male , Middle Aged , Predictive Value of Tests , Radionuclide Imaging , Stroke Volume , Survival Analysis
19.
Gastrointest Endosc ; 46(1): 1-7, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9260697

ABSTRACT

BACKGROUND: Male alcoholics hospitalized with actively bleeding esophageal varices were treated with sclerotherapy or sham sclerotherapy and the outcomes during the index hospitalization were compared. METHODS: The 87 patients were a subset of 253 patients enrolled in a prospective, randomized, single-blind, multicenter, controlled trial conducted in 12 VA medical centers. The patients (44 sclerotherapy, 43 sham therapy) were actively bleeding from esophageal varices at either randomization endoscopy (49) or follow-up endoscopy (38). Events and resource use during the index hospitalization were recorded. RESULTS: In 40 (91%) of the sclerotherapy and 26 (60%) of the sham therapy patients, bleeding was stopped during the endoscopy session (p < 0.001). During the hospitalization, 10 (25%) sclerotherapy and 21 (49%) sham therapy patients died (p = 0.04, relative risk 2.17, 95% CI [1.02, 4.61]); 9 sclerotherapy and 22 sham therapy patients rebled (p = 0.005). The median transfusion requirement was higher for sham therapy (8 vs 4 units, p = 0.001), the number of median ICU hours was greater (101 vs 55, p < 0.001), and more patients in this group required shunt surgery (6 vs 0, p = 0.01). CONCLUSION: Sclerotherapy, compared to no sclerotherapy, stops hemorrhage from actively bleeding esophageal varices and reduces use of resources. Sclerotherapy significantly increased hospital survival.


Subject(s)
Esophageal and Gastric Varices/therapy , Gastrointestinal Hemorrhage/therapy , Liver Cirrhosis, Alcoholic/complications , Sclerotherapy , Alcoholism/complications , Endoscopy, Digestive System , Esophageal and Gastric Varices/complications , Esophageal and Gastric Varices/diagnosis , Follow-Up Studies , Gastrointestinal Hemorrhage/diagnosis , Gastrointestinal Hemorrhage/etiology , Gastrointestinal Hemorrhage/mortality , Hospital Mortality , Hospitalization , Humans , Liver Cirrhosis, Alcoholic/diagnosis , Liver Cirrhosis, Alcoholic/mortality , Male , Middle Aged , Retrospective Studies , Sclerotherapy/methods , Single-Blind Method , Treatment Outcome
20.
Ann Intern Med ; 126(12): 939-45, 1997 Jun 15.
Article in English | MEDLINE | ID: mdl-9182470

ABSTRACT

BACKGROUND: Markers are needed for assessing response to antiretroviral therapy over time. The CD4+ lymphocyte count is one such surrogate, but it is relatively weak. OBJECTIVE: To assess the association of changes in plasma human immunodeficiency virus (HIV) RNA level and CD4+ lymphocyte count with progression to the acquired immunodeficiency syndrome (AIDS). DESIGN: Analysis of data from a subset of patients in a multicenter, randomized, clinical trial. SETTING: Six Veterans Affairs medical centers and one U.S. Army medical center. PATIENTS: 270 symptomatic HIV-infected patients from the Veterans Affairs Cooperative Study on AIDS. INTERVENTION: Patients were randomly assigned to receive zidovudine or placebo initially; a cross-over protocol was established for patients receiving placebo who had disease progression. MEASUREMENTS: Reverse transcriptase polymerase chain reaction on cryopreserved plasma samples, previously obtained CD4+ lymphocyte counts, and clinical events. RESULTS: For each decrease of 0.5 log10 copies/mL in plasma HIV RNA level, averaged over the 6 months after randomization, the relative risk (RR) for progression to AIDS was 0.67 (P < 0.001). In a subset of 70 treated patients with long-term follow-up, a return to baseline plasma HIV RNA levels within 6 months of randomization was associated with progression to AIDS (RR, 4.28; P = 0.004). Plasma HIV RNA levels or CD4+ lymphocyte counts over time were more strongly associated with progression to AIDS than were baseline levels or counts. CONCLUSIONS: An adequate virologic response after initiation of antiretroviral therapy seems to require a decrease in plasma HIV RNA level of at least 0.5 log10 copies/mL that is sustained for at least 6 months. The independent relation between plasma HIV RNA level and CD4+ lymphocyte count over time and clinical outcome suggests that the measurement of plasma HIV RNA level, in addition to the CD4+ lymphocyte count, has a role in guiding the management of antiretroviral therapy.


Subject(s)
Acquired Immunodeficiency Syndrome/blood , Acquired Immunodeficiency Syndrome/drug therapy , CD4 Lymphocyte Count , HIV-1/genetics , Monitoring, Physiologic/methods , RNA, Viral/blood , Viral Load , Acquired Immunodeficiency Syndrome/virology , Adult , Anti-HIV Agents/therapeutic use , Disease Progression , Humans , Treatment Failure , Zidovudine/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...